Welcome to LookChem.com Sign In|Join Free
  • or
4-Bromo-N-tert-butyl-3-methylbenzenesulfonamide is a chemical compound with the molecular formula C10H14BrNO2S. It is a sulfonamide derivative that features a tert-butyl group and a bromine substituent on the benzene ring. 4-Bromo-N-tert-butyl-3-methylbenzenesulfonamide is known for its potential as a carbonic anhydrase inhibitor and is utilized in the pharmaceutical industry for the development of drugs targeting conditions such as glaucoma and epilepsy. Additionally, the presence of a bromine atom in its structure makes it a valuable starting material for the synthesis of a variety of other organic compounds.

958651-46-2

Post Buying Request

958651-46-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

958651-46-2 Usage

Uses

Used in Pharmaceutical Industry:
4-Bromo-N-tert-butyl-3-methylbenzenesulfonamide is used as a building block for the development of drugs, particularly those targeting carbonic anhydrase enzymes. Its inhibitory action on these enzymes makes it a promising candidate for treating conditions such as glaucoma and epilepsy, where modulation of carbonic anhydrase activity can help manage symptoms and improve patient outcomes.
Used in Organic Synthesis:
As a reagent in organic synthesis, 4-Bromo-N-tert-butyl-3-methylbenzenesulfonamide is employed to facilitate the creation of various organic compounds. Its unique structure, which includes a bromine atom, allows for a range of synthetic reactions that can lead to the formation of new molecules with diverse applications across different industries.
Used in Research and Development:
4-Bromo-N-tert-butyl-3-methylbenzenesulfonamide is also utilized in research and development settings, where its properties and reactivity are studied to explore new applications and improve existing synthetic methods. This can lead to advancements in the fields of chemistry and medicine, as well as the discovery of new compounds with potential therapeutic uses.

Check Digit Verification of cas no

The CAS Registry Mumber 958651-46-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,8,6,5 and 1 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 958651-46:
(8*9)+(7*5)+(6*8)+(5*6)+(4*5)+(3*1)+(2*4)+(1*6)=222
222 % 10 = 2
So 958651-46-2 is a valid CAS Registry Number.

958651-46-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Bromo-N-(tert-butyl)-3-methylbenzenesulfonamide

1.2 Other means of identification

Product number -
Other names 4-bromo-N-tert-butyl-3-methylbenzenesulfonamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:958651-46-2 SDS

958651-46-2Relevant academic research and scientific papers

Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of Type-2 diabetes

Kitas, Eric,Mohr, Peter,Kuhn, Bernd,Hebeisen, Paul,Wessel, Hans Peter,Haap, Wolfgang,Ruf, Armin,Benz, Joerg,Joseph, Catherine,Huber, Walter,Sanchez, Ruben Alvarez,Paehler, Axel,Benardeau, Agnes,Gubler, Marcel,Schott, Brigitte,Tozzo, Effie

supporting information; experimental part, p. 594 - 599 (2010/05/19)

Sulfonylureido thiazoles were identified from a HTS campaign and optimized through a combination of structure-activity studies, X-ray crystallography and molecular modeling to yield potent inhibitors of fructose-1,6-bisphosphatase. Compound 12 showed favo

2,4,6-TRISUBSTITUTED PYRIDO (3,2-d) PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS

-

Page/Page column 74, (2010/04/03)

Pyrido(3,2-d)pyrimidine derivatives represented by the structural formuia (Ia): wherein, R1, R2 and R3 are defined herein, pharmaceutical acceptable addition salts, stereochemical isomeric forms, N-oxides, solvates and pro

New FBPase inhibitors for diabetes

-

Page/Page column 18-19, (2008/06/13)

Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in the application and which can be used in the form of pharmaceutical compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 958651-46-2